After atai Life Sciences (NASDAQ: ATAI) shared the results of subsidiary Perception Neuroscience’s Phase 2 trial of R-ketamine compound for TRD, the psyche
On Monday, shares of IntelGenx Technologies Corp. (OTC: IGXT) experienced volatile short activity. After the activity, the stock price went up +7.69% to $0.13.
The overall sentiment for IGXT has been Bearish.